학술논문
Rosiglitazone (PPAR gamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
14628902